Research Article
BibTex RIS Cite

EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION

Year 1998, Volume: 32 , 51 - 54, 09.09.2015

Abstract

Pek qok saligmada sigara kullananlarm diisiik HDL-kolesterol diizeylerine sahip oldugu ve bunun koroner kalp hastahg~ (JXH) riskinin artmaslyla sonuslandigi gosterilmigtir. KKH'dan oliimler sigara i~enlerde ismeyedere oranla onernli derecede yiiksektir. Bu ~ahgmada 78 sa@kh ve 48 miokard infarktiisii.tarus~ konmug hastada serum lipid profilleri saptanrmg ve sigara kullarumm serum lipid profili da@- mina etkisi incelemigtir. Serum lipid diizeyleri enzimatik metodlarla tayin edilmi~tirSigara kullanan grupta HDL kolesterol duzeyleri sigara kullanmayan pba gore istatistiksel olarak anlamh derecede dugiik bulundu (p=0.007).

References

  • 1. Dollery, C., Brenlan, P.J., Anz. Heart J., 115,276-281 (1988).
  • 2. Muscat, J.E., Harris, R.E., Haley, N.J., Wynder, E.L., Anz. Heart J., 121, 141-7 (1991).
  • 3. Richmond, W., Clin. Cfzem., 19, 1350-1356 (1973).
  • 4. Onaka, L., In: Clinical Chemistry Concepts and Applications. Anderson, S.C., Cockayne, S. Saunders, London (1993).
  • 5. Mc Gowan, M.W., Artiss, J.D., Stranbergh, D.R., Zak, B.A., Clin. Ckenz., 29, 538-542 (1983).
  • 6. Myos, O.D., Anz. Heart J., 115,272 (1988. Austin, M.A., King, M.C., Vranizan, K.M., Krauss, R.M., Circulation 82,495-506 (1990).

EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION

Year 1998, Volume: 32 , 51 - 54, 09.09.2015

Abstract

Several studies have shown that smoking lowers high density lipoprotein
levels, resulting in an increased risk of coronary heart disease (CHD). Mortality
from coronary heart disease is substantially higher in cigarette smokers thaq in
nonsmokers.
In this study, serum lipid profile was studied prospectively in healthy
adults and in A group of patients with acute or old myocardial infarction. Serum
lipid levels were measured enzymatically.
Serum HDL cholesterol levels of smoking group was found lower than
nonsmoking group with statistical significance (p=0.007).

References

  • 1. Dollery, C., Brenlan, P.J., Anz. Heart J., 115,276-281 (1988).
  • 2. Muscat, J.E., Harris, R.E., Haley, N.J., Wynder, E.L., Anz. Heart J., 121, 141-7 (1991).
  • 3. Richmond, W., Clin. Cfzem., 19, 1350-1356 (1973).
  • 4. Onaka, L., In: Clinical Chemistry Concepts and Applications. Anderson, S.C., Cockayne, S. Saunders, London (1993).
  • 5. Mc Gowan, M.W., Artiss, J.D., Stranbergh, D.R., Zak, B.A., Clin. Ckenz., 29, 538-542 (1983).
  • 6. Myos, O.D., Anz. Heart J., 115,272 (1988. Austin, M.A., King, M.C., Vranizan, K.M., Krauss, R.M., Circulation 82,495-506 (1990).
There are 6 citations in total.

Details

Primary Language English
Subjects Pharmacology and Pharmaceutical Sciences
Journal Section Makaleler
Authors

H. Yilmaz, B. Ağaçhan M. Aydın, T. İsbir This is me

Publication Date September 9, 2015
Published in Issue Year 1998 Volume: 32

Cite

APA M. Aydın, T. İsbir, H. Y. B. A. (2015). EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION. Journal of Faculty of Pharmacy of Istanbul University, 32, 51-54.
AMA M. Aydın, T. İsbir HYBA. EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION. Journal of Faculty of Pharmacy of Istanbul University. September 2015;32:51-54.
Chicago M. Aydın, T. İsbir, H. Yilmaz, B. Ağaçhan. “EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION”. Journal of Faculty of Pharmacy of Istanbul University 32, September (September 2015): 51-54.
EndNote M. Aydın, T. İsbir HYBA (September 1, 2015) EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION. Journal of Faculty of Pharmacy of Istanbul University 32 51–54.
IEEE H. Y. B. A. M. Aydın, T. İsbir, “EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION”, Journal of Faculty of Pharmacy of Istanbul University, vol. 32, pp. 51–54, 2015.
ISNAD M. Aydın, T. İsbir, H. Yilmaz, B. Ağaçhan. “EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION”. Journal of Faculty of Pharmacy of Istanbul University 32 (September 2015), 51-54.
JAMA M. Aydın, T. İsbir HYBA. EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION. Journal of Faculty of Pharmacy of Istanbul University. 2015;32:51–54.
MLA M. Aydın, T. İsbir, H. Yilmaz, B. Ağaçhan. “EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION”. Journal of Faculty of Pharmacy of Istanbul University, vol. 32, 2015, pp. 51-54.
Vancouver M. Aydın, T. İsbir HYBA. EFFECTS OF SMOKING ON SERUM LIPID PROFILE IN PATIENTS WITH MYOCARDIAL INFARCTION. Journal of Faculty of Pharmacy of Istanbul University. 2015;32:51-4.